Pfizer earnings Q4 2018 beat estimates

Pharmaceutical giant Pfizer braced investors for little-to-no revenue growth in 2019 after its blockbuster erectile dysfunction drug Viagra, among others, lost patent protection and pain killer Lyrica faces similar competition from generic drugmakers this year.

Source link

Leave a Comment

Apple Watch, using Aetna client data, wants to help you be healthyMiddlesbrough mental health hospital patient 'felt like caged animal'